Dacapobrain
1 known investors
Da Capo develops therapies aimed at halting the progression of neurodegenerative disease, using a target and drug discovery platform that combines data analytics, network biology, human iPS cell models, and chemistry and phenotypic screening. It focuses on recapitulating human neurodegenerative biology to identify disease drivers and move from target to lead compound.
AI & Machine LearningBiotechDeep Tech
Investors · 1
Frequently asked questions
- What does Dacapobrain do?
- Da Capo develops therapies aimed at halting the progression of neurodegenerative disease, using a target and drug discovery platform that combines data analytics, network biology, human iPS cell models, and chemistry and phenotypic screening. It focuses on recapitulating human neurodegenerative biology to identify disease drivers and move from target to lead compound.
- Who are Dacapobrain's investors?
- Dacapobrain's investors include Dns Capital.